Brief: Newbury Pharmaceuticals Appoints Karl Karlsson As CEO
Nov 11 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST: NEWBURY PHARMACEUTICALS APPOINTS ITS FOUNDER KARL KARLSSON AS NEW CEO LARS MINOR IS SIMULTANEOUSLY STEPPING DOWN FROM HIS ROLE AS CEO FOLLOWING AN AGREEMENT WITH BOARD OF DIRECTORS BOARD HAS APPOINTED IVAILO S. GEORGIEV, CURRENTLY A MEMBER OF BOARD, AS NEW CHAIRMAN OF BOARD Source text: ID:nMFN7n3j2J Further company coverage: NEWBRY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln